Standout Papers

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease... 2009 2026 2014 2020 1.1k
  1. Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease (2009)
    Alison D. Lydecker, Karen F. Murray et al. Clinical Gastroenterology and Hepatology

Immediate Impact

3 from Science/Nature 94 standout
Sub-graph 1 of 16

Citing Papers

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
1 intermediate paper

Works of Alison D. Lydecker being referenced

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2009 Standout

Author Peers

Author Last Decade Papers Cites
Alison D. Lydecker 272 1211 58 687 335 30 1.6k
Archana Sud 292 1179 36 789 256 39 1.8k
Paola Scognamiglio 465 738 47 709 178 57 1.9k
Jiaofeng Huang 837 880 42 283 298 46 2.0k
Yinlian Wu 610 683 30 248 240 27 1.5k
Laura Pimpin 731 747 122 265 111 21 2.1k
Vikas Singla 509 608 28 390 134 85 1.5k
Jennifer C. Price 177 808 94 693 90 84 1.4k
Eva Wolf 843 779 47 432 155 108 2.2k
Tamsin A. Knox 736 631 102 281 99 53 2.2k
Peter B. Gregory 152 1288 8 1081 44 46 2.1k

All Works

Loading papers...

Rankless by CCL
2026